H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK

Oncogene

Volumn 35, Issue 6, 2016, Pages 793-799

  Olcina, M M ^a   Leszczynska, K B ^a   Senra, J M ^a   Isa, N F ^a   Harada, H ^b   Hammond, E M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATM AND P53 ASSOCIATED KZNF PROTEIN; HISTONE H3; HISTONE H3K9; MESSENGER RNA; METHYLTRANSFERASE; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; DNA BINDING PROTEIN; HIF1A PROTEIN, HUMAN; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; TP53 PROTEIN, HUMAN; ZNF420 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HETEROCHROMATIN; HISTONE METHYLATION; HUMAN; HYPOXIA; OVERALL SURVIVAL; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; CELL HYPOXIA; DRUG EFFECTS; GENE SILENCING; GENETICS; HCT 116 CELL LINE; METABOLISM; PHYSIOLOGY; TUMOR CELL CULTURE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL HYPOXIA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84958060718     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.134     Document Type: Article

References (29)

1. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-1416.
2. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
3. Hammond EM, Denko NC, Dorie MJ, Abraham RT, Giaccia AJ. Hypoxia links ATR and p53 through replication arrest. Mol Cell Biol 2002; 22: 1834-1843.
4. Bencokova Z, Kaufmann MR, Pires IM, Lecane PS, Giaccia AJ, Hammond EM. ATM activation and signaling under hypoxic conditions. Mol Cell Biol 2009; 29: 526-537.
5. Hammond EM, Mandell DJ, Salim A, Krieg AJ, Johnson TM, Shirazi HA et al. Genomewide analysis of p53 under hypoxic conditions. Mol Cell Biol 2006; 26: 3492-3504.
6. Olcina MM, Foskolou IP, Anbalagan S, Senra JM, Pires IM, Jiang Y et al. Replication stress and chromatin context link ATM activation to a role in DNA replication. Mol Cell 2013; 52: 758-766.
7. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864-870.
8. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434: 907-913.
9. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW et al. Hypoxiamediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88-91.
10. Wang S, Tian C, Xing G, Gao M, Jiao W, Xiao T et al. ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress. FEBS Lett 2010; 584: 3909-3915.
11. Tian C, Xing G, Xie P, Lu K, Nie J, Wang J et al. KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol 2009; 11: 580-591.
12. Yuan L, Tian C, Wang H, Song S, Li D, Xing G et al. Apak competes with p53 for direct binding to intron 1 of p53AIP1 to regulate apoptosis. EMBO Rep 2012; 13: 363-370.
13. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705.
14. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129: 823-837.
15. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 2002; 16: 1779-1791.
16. Jenuwein T, Laible G, Dorn R, Reuter G. SET domain proteins modulate chromatin domains in eu-and heterochromatin. Cell Mol Life Sci 1998; 54: 80-93.
17. Loyola A, Tagami H, Bonaldi T, Roche D, Quivy JP, Imhof A et al. The HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep 2009; 10: 769-775.
18. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406: 593-599.
19. Rai G, Kawamura A, Tumber A, Liang Y, Vogel JL, Arbuckle JH et al. Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity. Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD), 2010.
20. Johnson AB, Barton MC. Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutat Res 2007; 618: 149-162.
21. Lu Y, Chu A, Turker MS, Glazer PM. Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol 2011; 31: 3339-3350.
22. Lu Y, Wajapeyee N, Turker MS, Glazer PM. Silencing of the dna mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1. Cell Rep 2014; 8: 501-513.
23. Vaupel P, Mayer A, Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol 2004; 381: 335-354.
24. Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010; 28: 817-825.
25. Mungamuri SK, Benson EK, Wang S, Gu W, Lee SW, Aaronson SA. p53-mediated heterochromatin reorganization regulates its cell fate decisions. Nat Struct Mol Biol 2012; 19: 478-484 S471.
26. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ. 3rd SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002; 16: 919-932.
27. Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 2010; 18: 619-629.
28. Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2009; 2: 18.
29. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010; 138: 958-968.